Cerus (CERS) Competitors $1.36 -0.01 (-0.73%) Closing price 07/18/2025 04:00 PM EasternExtended Trading$1.36 +0.00 (+0.37%) As of 07/18/2025 06:31 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Competitors Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFDA EventsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrendsBuy This Stock CERS vs. STAA, OSUR, UTMD, ANIK, WST, COO, ALGN, MMSI, HAE, and ICUIShould you be buying Cerus stock or one of its competitors? The main competitors of Cerus include STAAR Surgical (STAA), OraSure Technologies (OSUR), Utah Medical Products (UTMD), Anika Therapeutics (ANIK), West Pharmaceutical Services (WST), Cooper Companies (COO), Align Technology (ALGN), Merit Medical Systems (MMSI), Haemonetics (HAE), and ICU Medical (ICUI). These companies are all part of the "health care supplies" industry. Cerus vs. Its Competitors STAAR Surgical OraSure Technologies Utah Medical Products Anika Therapeutics West Pharmaceutical Services Cooper Companies Align Technology Merit Medical Systems Haemonetics ICU Medical Cerus (NASDAQ:CERS) and STAAR Surgical (NASDAQ:STAA) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their valuation, risk, earnings, dividends, institutional ownership, media sentiment, profitability and analyst recommendations. Which has better valuation & earnings, CERS or STAA? STAAR Surgical has higher revenue and earnings than Cerus. Cerus is trading at a lower price-to-earnings ratio than STAAR Surgical, indicating that it is currently the more affordable of the two stocks. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioCerus$180.27M1.44-$20.92M-$0.10-13.60STAAR Surgical$313.90M2.74-$20.21M-$1.44-12.06 Which has more risk & volatility, CERS or STAA? Cerus has a beta of 1.56, suggesting that its share price is 56% more volatile than the S&P 500. Comparatively, STAAR Surgical has a beta of 0.58, suggesting that its share price is 42% less volatile than the S&P 500. Is CERS or STAA more profitable? Cerus has a net margin of -10.23% compared to STAAR Surgical's net margin of -25.46%. STAAR Surgical's return on equity of -10.59% beat Cerus' return on equity.Company Net Margins Return on Equity Return on Assets Cerus-10.23% -34.81% -9.68% STAAR Surgical -25.46%-10.59%-8.32% Do analysts prefer CERS or STAA? Cerus currently has a consensus price target of $3.50, suggesting a potential upside of 157.35%. STAAR Surgical has a consensus price target of $18.00, suggesting a potential upside of 3.69%. Given Cerus' stronger consensus rating and higher possible upside, research analysts plainly believe Cerus is more favorable than STAAR Surgical.Company Sell Ratings Hold Ratings Buy Ratings Strong Buy Ratings Rating Score Cerus 0 Sell rating(s) 0 Hold rating(s) 2 Buy rating(s) 0 Strong Buy rating(s) 3.00STAAR Surgical 0 Sell rating(s) 9 Hold rating(s) 1 Buy rating(s) 0 Strong Buy rating(s) 2.10 Does the media prefer CERS or STAA? In the previous week, STAAR Surgical had 4 more articles in the media than Cerus. MarketBeat recorded 4 mentions for STAAR Surgical and 0 mentions for Cerus. STAAR Surgical's average media sentiment score of 0.68 beat Cerus' score of 0.00 indicating that STAAR Surgical is being referred to more favorably in the news media. Company Overall Sentiment Cerus Neutral STAAR Surgical Positive Do institutionals and insiders hold more shares of CERS or STAA? 78.4% of Cerus shares are owned by institutional investors. Comparatively, 96.7% of STAAR Surgical shares are owned by institutional investors. 3.4% of Cerus shares are owned by company insiders. Comparatively, 1.0% of STAAR Surgical shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a stock will outperform the market over the long term. SummarySTAAR Surgical beats Cerus on 9 of the 16 factors compared between the two stocks. Get Cerus News Delivered to You Automatically Sign up to receive the latest news and ratings for CERS and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding CERS and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart CERS vs. The Competition Export to ExcelMetricCerusMED PRODUCTS IndustryMedical SectorNASDAQ ExchangeMarket Cap$259.98M$10.27B$5.53B$9.41BDividend YieldN/A2.07%4.00%4.04%P/E Ratio-13.6017.1828.2519.76Price / Sales1.4430.01412.1989.25Price / CashN/A22.8224.9928.17Price / Book4.393.548.095.69Net Income-$20.92M$232.65M$3.25B$257.97M7 Day Performance-6.21%-1.67%1.63%3.74%1 Month Performance1.49%3.18%7.62%11.95%1 Year Performance-38.18%-16.06%32.74%19.22% Cerus Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)CERSCerus1.8695 of 5 stars$1.36-0.7%$3.50+157.4%-38.2%$259.98M$180.27M-13.60290STAASTAAR Surgical3.2272 of 5 stars$17.30-0.5%$24.63+42.3%-59.2%$856.87M$313.90M-12.011,211Analyst ForecastGap UpOSUROraSure Technologies2.6899 of 5 stars$3.07-1.0%$3.00-2.3%-23.8%$229.64M$185.83M-7.31840Positive NewsHigh Trading VolumeUTMDUtah Medical Products2.2177 of 5 stars$56.69+0.5%N/A-20.6%$184.24M$40.90M15.00180Positive NewsUpcoming EarningsANIKAnika Therapeutics4.0687 of 5 stars$11.53+2.3%$20.00+73.5%-61.9%$165.35M$117.05M-2.97300WSTWest Pharmaceutical Services4.779 of 5 stars$224.66-1.1%$320.00+42.4%-33.7%$16.14B$2.89B35.2710,600Upcoming EarningsCOOCooper Companies3.2666 of 5 stars$73.61-1.6%$99.70+35.4%-20.0%$14.72B$3.90B35.7316,000Analyst ForecastALGNAlign Technology4.8635 of 5 stars$199.31-1.5%$242.92+21.9%-24.2%$14.45B$4.00B36.3020,945News CoverageAnalyst RevisionMMSIMerit Medical Systems4.6181 of 5 stars$93.450.0%$109.11+16.8%-2.9%$5.52B$1.36B45.817,400Positive NewsAnalyst ForecastHAEHaemonetics4.8788 of 5 stars$76.59+1.4%$97.30+27.0%-18.3%$3.68B$1.36B23.143,023News CoverageICUIICU Medical4.3527 of 5 stars$130.85-1.0%$192.67+47.2%+0.1%$3.22B$2.42B-34.1615,000News CoveragePositive News Related Companies and Tools Related Companies STAA Competitors OSUR Competitors UTMD Competitors ANIK Competitors WST Competitors COO Competitors ALGN Competitors MMSI Competitors HAE Competitors ICUI Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:CERS) was last updated on 7/20/2025 by MarketBeat.com Staff From Our PartnersCongress Is Talking Crypto. Here’s What It Means for You …Congress is deep into “Crypto Week” — with new bills that could finally bring clarity to digital assets. Cr...Weiss Ratings | SponsoredTurn $1K into $50K with This DeFi GemTHREE pro-crypto bills just passed the House! Now, experts believe altcoin season is officially here. Crypto 101 Media | SponsoredGenesis 14:13-17 [HIDDEN MEANING?]A mysterious Bible verse from Genesis may hold the key to unlocking what one expert calls an “American birthri...Paradigm Press | SponsoredBuffett to put 90% of his money in this one stock?CPA and CFA says you have WAY too many stocks - just buy these 3 After years working at the biggest accoun...Altimetry | SponsoredThis Could Be the Most Profitable Season of Your LifeInstitutional money is pouring in. Bitcoin ETFs are live. Altcoin adoption is accelerating. This is the sam...Crypto Swap Profits | SponsoredBitcoin just humbled Jeff BezosBitcoin just passed Amazon in total market cap — but most investors are missing the bigger opportunity. Whi...Brownstone Research | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredCritical AI announcement set to ignite AI 2.0 I just put together an urgent new presentation that you need to see right away. In short: I believe we are...Timothy Sykes | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Cerus Corporation Please log in to your account or sign up in order to add this asset to your watchlist. Share Cerus With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free CERS Stock Alerts